SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1682.6000 10.60 (0.63%)

NSE Jul 14, 2025 15:31 PM

Volume: 1.3M

Sun Pharmaceutical Industries Ltd.

19 Jun 2024

1682.60

0.63%

Company Update

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Intimation regarding Warning Letter from US FDA

More from Sun Pharmaceutical Industries Ltd.

Recommended

IPO spree continues with Anthem and two SME issues opening this week

| 14 Jul 2025, 04:42PM

Market closes lower, Ahluwalia Contracts bags a Rs 2,089 crore order from DLF

Trendlyne Marketwatch | 14 Jul 2025, 03:56PM

Change is hard, and some Indian pharma companies are embracing it better than others